Fibrocor Therapeutics Inc. ('Fibrocor' or 'the Company'), a biotech company developing first-in-class therapies for kidney diseases, with a strong focus on Alport Syndrome, today announces the ...

From microglia reprogramming to immune cell-based diagnostics, 2025 was a big year for breakthroughs in cell biology.

A new article reflects on how two generations of scientists reshaped thinking on aging, linking hormonal regulation in the brain to molecular growth pathways. Mikhail Blagosklonny spent his career ...

Combination Potential: When combined with an anti-PD-1 antibody, Compound 10 significantly inhibited tumor growth, ...

Qihan's QT-019B program is supported by IND clearance for rSLE from both the US FDA and the China NMPA. The FDA has also granted Fast Track Designation for the SLE-ITP indication. Phase 1 enrollment ...

Xu, W. , Xing, X. and Cheng, S. (2025) Urine-Based Liquid Biopsy for Detecting Recurrence of Bladder Cancer. International ...

Chonnam National University has once again solidified its international reputation as Korea's leading institution in "nano-regenerative medicine" ...

Protecting biodiversity and natural ecosystems is vital for human health, medicine discovery, and sustainable wellbeing.

Today, The Jackson Laboratory (JAX) announced a bold initiative to improve that trajectory, powered by an up to $30 million contract from the Advanced Research Projects Agency for Health (ARPA-H) ...

Dietary iron deficiency in mice alters lung T cell activation during influenza infection and leads to memory T cells that are ...

Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...

Cell death triggered by GPX4 loss was slowed in cell cultures and in mouse model using compounds that specifically inhibit ferroptosis.